Patent ID: 6423724
Filing Date: 2002-07-23
Classification: A61K,C07D

Abstract:
A method for preventing or treating a disorder modulated by alpha-2 adrenoceptors by administering to a mammal in need of such treatment, a safe and effective amount of an alpha-2 adrenocepter agonist having the following structure: (a) R is unsubstituted alkanyl or alkenyl having from 1 to about 3 carbon atoms; cycloalkanyl; cycloalkenyl; and (b) Râ€² is selected from the group consisting of hydrogen; unsubstituted alkanyl or alkenyl having from 1 to about 3 carbon atoms; unsubstituted alkylthio or alkoxy having from 1 to about 3 carbon atoms; hydroxy; thiol; cyano; and halo.